-+ 0.00%
-+ 0.00%
-+ 0.00%

OnKure Therapeutics Q2 2025 Results: Net Loss Widened to $15.4M, EPS at $1.14, R&D Expenses Increased to $12.6M

Reuters·08/12/2025 20:21:14

Please log in to view news